{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:45:13Z","timestamp":1777643113704,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016286","name":"Urmia University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.lfs.2023.122083","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T14:58:31Z","timestamp":1694962711000},"page":"122083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers"],"prefix":"10.1016","volume":"332","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2636-9856","authenticated-orcid":false,"given":"Fahima Danesh","family":"Pouya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-0055","authenticated-orcid":false,"given":"Roya","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-1909","authenticated-orcid":false,"given":"Yousef","family":"Rasmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7886-8251","authenticated-orcid":false,"given":"Fatemeh","family":"Kheradmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-9802","authenticated-orcid":false,"given":"Anahita","family":"Fathi-Azarbayjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.122083_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13304-016-0359-y","article-title":"Worldwide burden of colorectal cancer: a review","volume":"68","author":"Favoriti","year":"2016","journal-title":"Updat. Surg."},{"key":"10.1016\/j.lfs.2023.122083_bb0010","first-page":"105","article-title":"Epidemiology of colorectal cancer","volume":"7","author":"Marley","year":"2016","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"10.1016\/j.lfs.2023.122083_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1200\/jco.2012.30.4_suppl.381","article-title":"Phase II study of sunitinib (SU) in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor (NET)","volume":"30","author":"Okusaka","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2023.122083_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2023.122083_bb0025","series-title":"Capecitabine Therapy and DPYD Genotype","author":"Dean","year":"2020"},{"key":"10.1016\/j.lfs.2023.122083_bb0030","first-page":"1","article-title":"Performance of capecitabine in novel combination therapies in colorectal cancer","author":"Pouya","year":"2021","journal-title":"J. Chemother."},{"key":"10.1016\/j.lfs.2023.122083_bb0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00001813-200109000-00001","article-title":"Capecitabine: a novel agent for the treatment of solid tumors","volume":"12","author":"Johnston","year":"2001","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.lfs.2023.122083_bb0040","first-page":"79","article-title":"Capecitabine in the management of colorectal cancer","volume":"3","author":"Hirsch","year":"2011","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.122083_bb0045","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s12253-019-00587-3","article-title":"Comparison of capecitabine (xeloda) vs. combination of capecitabine and oxaliplatin (XELOX) as neoadjuvant CRT for locally advanced rectal cancer","volume":"25","author":"Yaghobi","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.lfs.2023.122083_bb0050","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.ejca.2013.03.004","article-title":"Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history","volume":"49","author":"Kelly","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2023.122083_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ncponc1240","article-title":"Capecitabine: have we got the dose right?","volume":"6","author":"Midgley","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2023.122083_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","article-title":"Capecitabine: a review","volume":"27","author":"Walko","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.lfs.2023.122083_bb0065","doi-asserted-by":"crossref","DOI":"10.1208\/pt070374","article-title":"Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer","volume":"7","author":"Chaurasia","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.lfs.2023.122083_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.seminoncol.2004.09.028","article-title":"Oral capecitabine: bridging the Atlantic divide in colon cancer treatment","author":"Van Cutsem","year":"2005","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.lfs.2023.122083_bb0075","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2023.122083_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejphar.2016.09.010","article-title":"Pioglitazone inhibits EGFR\/MDM2 signaling-mediated PPAR\u03b3 degradation","volume":"791","author":"Shi","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122083_bb0085","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association","volume":"108","author":"Nesto","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2023.122083_bb0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/pharmaceutics14020425","article-title":"Design and optimization of pioglitazone hydrochloride self-nanoemulsifying drug delivery system (SNEDDS) incorporated into an orally disintegrating tablet","volume":"14","author":"Teaima","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2023.122083_bb0095","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1039\/C4NR01763C","article-title":"A quantitative study of the intracellular concentration of graphene\/noble metal nanoparticle composites and their cytotoxicity","volume":"6","author":"Zhou","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.lfs.2023.122083_bb0100","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1021\/acs.chemrev.7b00258","article-title":"Nanotechnology for multimodal synergistic cancer therapy","volume":"117","author":"Fan","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.lfs.2023.122083_bb0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/cgt.2010.18","article-title":"MicroRNA and drug resistance","volume":"17","author":"Ma","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.lfs.2023.122083_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1248\/bpb.b13-00540","article-title":"Selective delivery of oxaliplatin to tumor tissue by nanocarrier system enhances overall therapeutic efficacy of the encapsulated oxaliplatin","volume":"37","author":"Lila","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2023.122083_bb0115","first-page":"77","article-title":"Nanoparticles and nanofibers for topical drug delivery","volume":"240","author":"Goyal","year":"2016","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.lfs.2023.122083_bb0120","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1161\/ATVBAHA.112.253823","article-title":"Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia","volume":"32","author":"Nagahama","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2023.122083_bb0125","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1039\/C5TB01425E","article-title":"A poly-l-glutamic acid functionalized nanocomplex for improved oral drug absorption","volume":"3","author":"Zhu","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.lfs.2023.122083_bb0130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/10717544.2013.801052","article-title":"Efficacy of methotrexate-loaded poly (\u03b5-caprolactone) implants in Ehrlich solid tumor-bearing mice","volume":"20","author":"Pereira","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.lfs.2023.122083_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ddr.10396","article-title":"Preparation and characterization of 5-fluorouracil-loaded poly (\u03f5-caprolactone) microspheres for drug administration","volume":"63","author":"Sastre","year":"2004","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.lfs.2023.122083_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pat.138","article-title":"Degradation and 5-fluorouracil release behavior in vitro of polycaprolactone\/poly (ethylene oxide)\/polylactide tri-component copolymer\u2020 1","volume":"12","author":"Wang","year":"2001","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.lfs.2023.122083_bb0145","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/app.25321","article-title":"Synthesis and biodegradability evaluation of 2-methylene-1, 3-dioxepane and styrene copolymers","volume":"103","author":"Xu","year":"2007","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.lfs.2023.122083_bb0150","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1021\/acsami.5b02685","article-title":"Injectable chitin-poly (\u03b5-caprolactone)\/nanohydroxyapatite composite microgels prepared by simple regeneration technique for bone tissue engineering","volume":"7","author":"Arun Kumar","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.lfs.2023.122083_bb0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2022.01.035","article-title":"PCL-PEG copolymer based injectable thermosensitive hydrogels","volume":"343","author":"Dethe","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2023.122083_bb0160","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41598-020-58527-0","article-title":"Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells","volume":"10","author":"Jalilzadeh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122083_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15171\/apb.2017.003","article-title":"Novel pentablock copolymers as thermosensitive self-assembling micelles for ocular drug delivery","volume":"7","author":"Alami-Milani","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.lfs.2023.122083_bb0170","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/macp.200600100","article-title":"Synthesis of three types of amphiphilic poly (ethylene glycol)-block-poly (sebacic anhydride) copolymers and studies of their micellar solutions","volume":"207","author":"Zhang","year":"2006","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.lfs.2023.122083_bb0175","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.2147\/IJN.S33607","article-title":"Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles","author":"Feng","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2023.122083_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijpharm.2016.11.047","article-title":"Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: in vitro and in vivo evaluation","volume":"516","author":"Hu","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2023.122083_bb0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mtchem.2018.03.005","article-title":"Effects of PCL, PEG and PLGA polymers on curcumin release from calcium phosphate matrix for in vitro and in vivo bone regeneration","volume":"8","author":"Bose","year":"2018","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.lfs.2023.122083_bb0190","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijbiomac.2020.02.326","article-title":"Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis","volume":"152","author":"Luo","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2023.122083_bb0195","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acsbiomaterials.9b01947","article-title":"Hyperbranched polymer-functionalized magnetic nanoparticle-mediated hyperthermia and niclosamide bimodal therapy of colorectal cancer cells","volume":"6","author":"Ahmad","year":"2019","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.lfs.2023.122083_bb0200","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1021\/acsabm.1c00437","article-title":"Aminocellulose-grafted polymeric nanoparticles for selective targeting of CHEK2-deficient colorectal cancer","volume":"4","author":"Ahmad","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.lfs.2023.122083_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.colsurfb.2014.12.009","article-title":"Fabrication of a novel scaffold of clotrimazole-microemulsion-containing nanofibers using an electrospinning process for oral candidiasis applications","volume":"126","author":"Tonglairoum","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.lfs.2023.122083_bb0210","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.122083_bb0215","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2009.04.007","article-title":"Poly (\u025b-caprolactone)\u2013poly (ethylene glycol)\u2013poly (\u025b-caprolactone)(PCL\u2013PEG\u2013PCL) nanoparticles for honokiol delivery in vitro","volume":"375","author":"Gou","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2023.122083_bb0220","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.biopha.2016.10.095","article-title":"Synthesis and characterization of chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line","volume":"84","author":"Eatemadi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.122083_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-020-04345-0","article-title":"Ultrasound-assisted dispersive solid-phase microextraction of capecitabine by multi-stimuli responsive molecularly imprinted polymer modified with chitosan nanoparticles followed by HPLC analysis","volume":"187","author":"Ansari","year":"2020","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.lfs.2023.122083_bb0230","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s10973-013-3540-2","article-title":"Stability study of the gastric floating dosage form of capecitabine","volume":"115","author":"Davoudi","year":"2014","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.lfs.2023.122083_bb0235","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1002\/pat.5398","article-title":"Chitosan\/agarose-g-poly (methacrylate) pH responsive polymeric blend: a dais for controlled delivery of capecitabine","volume":"32","author":"Rehman","year":"2021","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.lfs.2023.122083_bb0240","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1039\/D1RA07791K","article-title":"Targeted delivery of capecitabine to colon cancer cells using nano polymeric micelles based on beta cyclodextrin","volume":"12","author":"Ameli","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.lfs.2023.122083_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7324\/JAPS.2016.600118","article-title":"Development of pioglitazone hydrochloride lipospheres by melt dispersion technique: optimization and evaluation","volume":"6","author":"Bhosale","year":"2016","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.lfs.2023.122083_bb0250","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/0973-8398.68470","article-title":"Effect of method of preparation on pioglitazone HCl-\u03b2-cyclodextrin inclusion complexes","volume":"4","author":"Beloshe","year":"2014","journal-title":"Asian J. Pharm."},{"key":"10.1016\/j.lfs.2023.122083_bb0255","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/10837450.2015.1116565","article-title":"Preparation and in vitro evaluation of 5-fluorouracil-loaded PCL nanoparticles for colon cancer treatment","volume":"22","author":"\u00d6zt\u00fcrk","year":"2017","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.lfs.2023.122083_bb0260","first-page":"1557","article-title":"Formulation and evaluation of polymeric nanoparticles of an antiviral drug for gastroretention","volume":"4","author":"Kharia","year":"2012","journal-title":"Int. J. Pharm. Sci. Nanotechnol."},{"key":"10.1016\/j.lfs.2023.122083_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","article-title":"Effect of chitosan on epithelial cell tight junctions","volume":"21","author":"Smith","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2023.122083_bb0270","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.biomaterials.2003.09.055","article-title":"Methoxy poly (ethylene glycol)-poly (lactide)(MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs","volume":"25","author":"Dong","year":"2004","journal-title":"Biomaterials."},{"key":"10.1016\/j.lfs.2023.122083_bb0275","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10544-007-9139-2","article-title":"Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells","volume":"10","author":"Zhang","year":"2008","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.lfs.2023.122083_bb0280","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1039\/C6NJ03332F","article-title":"Biocompatible magnetic tris (2-aminoethyl) amine functionalized nanocrystalline cellulose as a novel nanocarrier for anticancer drug delivery of methotrexate","volume":"41","author":"Rahimi","year":"2017","journal-title":"New J. Chem."},{"key":"10.1016\/j.lfs.2023.122083_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","article-title":"Control of encapsulation efficiency and initial burst in polymeric microparticle systems","volume":"27","author":"Yeo","year":"2004","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.lfs.2023.122083_bb0290","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2023.122083_bb0295","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrc1560","article-title":"The role of apoptosis in cancer development and treatment response","volume":"5","author":"Brown","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2023.122083_bb0300","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s004180100249","article-title":"Fluorescent dyes for cell viability: an application on prefixed conditions","volume":"115","author":"Foglieni","year":"2001","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.lfs.2023.122083_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2528935","article-title":"Modulation of hydrogen peroxide-induced oxidative stress in human neuronal cells by thymoquinone-rich fraction and thymoquinone via transcriptomic regulation of antioxidant and apoptotic signaling genes","volume":"2016","author":"Ismail","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2023.122083_bb0310","first-page":"19670","article-title":"Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Exp."},{"key":"10.1016\/j.lfs.2023.122083_bb0315","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10495-006-4003-z","article-title":"Pioglitazone, a synthetic ligand for PPAR\u03b3, induces apoptosis in RB-deficient human colorectal cancer cells","volume":"11","author":"Lee","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.lfs.2023.122083_bb0320","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/1061186X.2013.876645","article-title":"Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs","volume":"22","author":"Salehi","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.lfs.2023.122083_bb0325","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2021.12.011","article-title":"Effect of particle size on in vivo performances of long-acting injectable drug suspension","volume":"341","author":"Ho","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2023.122083_bb0330","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.2174\/138161206779026272","article-title":"Exploiting EPR in polymer drug conjugate delivery for tumor targeting","volume":"12","author":"Modi","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2023.122083_bb0335","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.lfs.2023.122083_bb0340","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijbiomac.2013.10.012","article-title":"Synthesis of chitosan based nanoparticles and their in vitro evaluation against phytopathogenic fungi","volume":"62","author":"Saharan","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2023.122083_bb0345","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijbiomac.2020.01.053","article-title":"Ouyang X-k: stabilization of zein nanoparticles with k-carrageenan and tween 80 for encapsulation of curcumin","volume":"146","author":"Sun","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2023.122083_bb0350","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/0142-9612(96)00049-X","article-title":"Stability study of nanoparticles of poly (\u025b-caprolactone), poly (d, l-lactide) and poly (d, l-lactide-co-glycolide)","volume":"17","author":"Lemoine","year":"1996","journal-title":"Biomaterials."},{"key":"10.1016\/j.lfs.2023.122083_bb0355","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ifset.2007.07.005","article-title":"The use of ultrasonics for nanoemulsion preparation","volume":"9","author":"Kentish","year":"2008","journal-title":"Innov. Food Sci. Emerg. Technol."},{"key":"10.1016\/j.lfs.2023.122083_bb0360","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00396-011-2476-y","article-title":"Effect of hydrophobic and hydrophilic additives on sol\u2013gel transition and release behavior of timolol maleate from polycaprolactone-based hydrogel","volume":"289","author":"Mishra","year":"2011","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.lfs.2023.122083_bb0365","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/2405461503666180501115359","article-title":"Design and characterization of polymeric nanoparticles of pioglitazone hydrochloride and study the effect of formulation variables using QbD approach","volume":"2","author":"Canchi","year":"2017","journal-title":"Curr. Nanomater."},{"key":"10.1016\/j.lfs.2023.122083_bb0370","first-page":"1","article-title":"Gao W-q, Zhang Y: CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients","volume":"21","author":"Lu","year":"2020","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.lfs.2023.122083_bb0375","first-page":"1","article-title":"Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK\/RANKL pathway","volume":"23","author":"Shao","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2023.122083_bb0380","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/10717544.2014.887156","article-title":"Pioglitazone hydrochloride: chemopreventive potential and development of site-specific drug delivery systems","volume":"22","author":"Sinha","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.lfs.2023.122083_bb0385","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.lfs.2023.122083_bb0390","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2217\/nnm.14.97","article-title":"Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment","volume":"9","author":"Su","year":"2014","journal-title":"Nanomedicine."},{"key":"10.1016\/j.lfs.2023.122083_bb0395","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.addr.2013.09.016","article-title":"Can nanomedicines kill cancer stem cells?","volume":"65","author":"Zhao","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2023.122083_bb0400","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1016\/j.biomaterials.2014.04.034","article-title":"Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer","volume":"35","author":"Lv","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2023.122083_bb0405","doi-asserted-by":"crossref","first-page":"1000164","DOI":"10.4172\/2157-7439.1000164","article-title":"Paclitaxel nano-delivery systems: a comprehensive review","volume":"4","author":"Ma","year":"2013","journal-title":"J. Nanomed. Nanotechnol."},{"key":"10.1016\/j.lfs.2023.122083_bb0410","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3109\/10717544.2015.1055619","article-title":"Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect","volume":"23","author":"Wang","year":"2016","journal-title":"Drug Deliv."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052300718X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052300718X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:57:14Z","timestamp":1736333834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052300718X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":82,"alternative-id":["S002432052300718X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122083","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122083"}}